Blockchain-Authenticated Sharing of Genomic and Clinical Outcomes Data of Patients With Cancer: A Prospective Cohort Study

Abstract

Background Efficiently sharing health data produced during standard care could dramatically accelerate progress in cancer treatments, but various barriers make this difficult. Not sharing these data to ensure patient privacy is at the cost of little to no learning from real-world data produced during cancer care. Furthermore, recent research has demonstrated a willingness of patients with cancer to share their treatment experiences to fuel research, despite potential risks to privacy. Objective The objective of this study was to design, pilot, and release a decentralized, scalable, efficient, economical, and secure strategy for the dissemination of deidentified clinical and genomic data with a focus on late-stage cancer. Methods We created and piloted a blockchain-authenticated system to enable secure sharing of deidentified patient data derived from standard of care imaging, genomic testing, and electronic health records (EHRs), called the Cancer Gene Trust (CGT). We prospectively consented and collected data for a pilot cohort (N=18), which we uploaded to the CGT. EHR data were extracted from both a hospital cancer registry and a common data model (CDM) format to identify optimal data extraction and dissemination practices. Specifically, we scored and compared the level of completeness between two EHR data extraction formats against the gold standard source documentation for patients with available data (n=17). Results Although the total completeness scores were greater for the registry reports than those for the CDM, this difference was not statistically significant. We did find that some specific data fields, such as histology site, were better captured using the registry reports, which can be used to improve the continually adapting CDM. In terms of the overall pilot study, we found that CGT enables rapid integration of real-world data of patients with cancer in a more clinically useful time frame. We also developed an open-source Web application to allow users to seamlessly search, browse, explore, and download CGT data. Conclusions Our pilot demonstrates the willingness of patients with cancer to participate in data sharing and how blockchain-enabled structures can maintain relationships between individual data elements while preserving patient privacy, empowering findings by third-party researchers and clinicians. We demonstrate the feasibility of CGT as a framework to share health data trapped in silos to further cancer research. Further studies to optimize data representation, stream, and integrity are required.

Blockchain applications in health care for COVID-19 and beyond: a systematic review

“…The platform facilitated access to genomic data by establishing a secure trading system through the use of tokens. Separately, Glicksberg and colleagues 70 conducted a prospective cohort study for dissemination of de-identified clinical and genomic data of patients with late-stage cancer and reported two key findings. The completeness of the electronic medical records extracted by the blockchain platform was comparable with registry reports, which allowed rapid dissemination of real-world data.…”

Sharing Biomedical Data: Strengthening AI Development in Healthcare

“…It has the potential to address interoperability challenges and has so far been proposed to address several security and privacy issues in a number of different applications in the biomedical sector [ 41 ], despite the inevitable tension with important data protection principles and individual rights, when considering the current state of the distributed technology [ 42 ]. Although this technology is still more associated with the financial area [ 43 ], nowadays, there are many pilot projects currently underway, such as FHIRChain [ 44 ], Cancer Gene Trust [ 45 ], and Zenome [ 46 ]. While the implementation of the blockchain technology in clinical routine can address critical issues related to privacy, legal compliance, avoiding fraud, and improving patient care in cases of remote or emergency monitoring, further production developments, detailed proof-of-concept applications, and research articles are crucial for this technology to move forward and be implemented in the biomedical field.…”

Is blockchain ready for orthopaedics? A systematic review

“…By facilitating a scalable, trusted data sharing framework for collaborators, 26,27 particularly on the international stage, blockchain provides new opportunities for the orthopaedic research community to aggregate data, particularly where study populations are small, for instance in the study of rare congenital and genetic musculoskeletal diseases. Collaborative blockchain solutions may also facilitate a more networked global arthroplasty registry system.…”